InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Scanlan Jacqueline, Responsable des Ressources Humaines. Insider active across 4 companies, notably HAEMONETICS CORP. Cumulatively, 18 disclosures have been logged. Split: 0 buy · 7 sells. Total volume traded: €886k. Activity tracked since 17 May 2021. The latest transaction was filed on 23 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Scanlan Jacqueline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
1,404 股@ US$14.622.4% 占其流量Common StockSEC:0000950103-26-002678:0
42,232 股0Common StockSEC:0000950103-26-002511:0
3,790 股@ US$34.0015.4% 占其流量Common StockSEC:0000037785-25-000088:0
1,510 股@ US$37.498.0% 占其流量Common StockSEC:0000037785-25-000085:0
9,084 股0Common StockSEC:0001127602-25-006516:0
583 股0Common StockSEC:0001127602-25-006105:0
4,529 股@ US$59.6745.4% 占其流量Common StockSEC:0001127602-24-027176:0
5,132 股@ US$65.9754.6% 占其流量Common StockSEC:0001127602-24-024581:0
4,799 股0Common StockSEC:0001127602-24-006254:0
33,511 股0Common StockSEC:0001127602-23-024846:0
17,008 股@ US$29.48100.0% 占其流量Common SharesSEC:0001209191-23-045443:0
16,266 股Common SharesSEC:0001209191-23-043717:0
2,873 股Common SharesSEC:0001209191-23-037971:0
3,238 股Common SharesSEC:0001209191-23-010829:0
2,873 股Common SharesSEC:0001209191-22-037534:0
195 股@ US$55.0947.4% 占其流量Common StockSEC:0001127602-21-019526:0
112 股@ US$55.1927.3% 占其流量Common StockSEC:0001127602-21-017698:0
102 股@ US$55.9725.3% 占其流量Common StockSEC:0001127602-21-017269:0
18 条申报中的 18 条
About Scanlan Jacqueline
Scanlan Jacqueline is Responsable des Ressources Humaines. She has 18 filings in total, and across the sampled recent filings between 2021-05-18 and 2026-02-25, sales amount to EUR 885898 and the most frequent transaction nature is Cession. The companies mentioned are FMC CORP, Axalta Coating Systems Ltd., and HAEMONETICS CORP.
